Pediatric cancer

Valérie Devillaine
04/21/2017
Share
Too many children and adolescents continue to die of cancer. This program aims to discover new therapeutic strategies for children for whom therapies are not working, and to reduce the after-effects of treatment for others.
Equipe Olivier Ayrault

Institut Curie is recognized for its treatment and research in the areas of childhood and adolescent cancers. To go even further and continue research in this area, in early 2017 the decision was made to create a dedicated division to strengthen the ties between the research teams and the Pediatrics department (for adolescents and young adults) in order to treat young patients at the hospital. Under the supervision of Olivier Delattre, the primary purpose of this new division will be to improve management and develop innovative therapies:

  • Ewing tumors are a form of bone sarcoma that affects growing adolescents.
  • Neuroblastoma is a tumor of the sympathetic nervous system in children.
  • Rhabdoid tumors are aggressive tumors that develop in very young children.
  • Medulloblastoma is a tumor that develops in the cerebellum of young children.
  • Retinoblastoma is a tumor of the eye.

Already well-established in Paris, research in pediatric oncology is also developing at the Orsay site:

  • Two research groups are working closely with the Proton Therapy center to optimize treatments for children.
  • Chemists are studying techniques using photo-sensitization for retinoblastoma. This program aims to improve the proportion of young patients who are able to keep their eyes and their vision, and to better understand the genetic predispositions involved in retinoblastoma.

Our commitment

To create a division bringing research teams together with the Pediatric, Adolescent and Young Adult department, to speed up the arrival of new therapeutic strategies for young patients.